Program (Subject to Change)

  • Dietary Supplements, Health Foods and Herbal Medicines: Regulations, Standards, and GMP Requirements
Dietary Supplements, Health Foods and Herbal Medicines: Regulations, Standards, and GMP Requirements


Share the program with your friends

View in Mobile

Date:06月18日 10:00 - 06月18日 18:00

Language: Chinese-English

Location:Hall E2 M19 Meeting Room Hall E2 M17 Meeting Room

Organizer:USP ,ChP


Introduction:Botanicals are regulated differently around the world either as drugs, health foods or dietary supplements. Several of the botanicals from the TCM are used as health foods in China and as dietary supplements in the United States and other countries, based on the claimed “intended use” of those products. This one-day workshop will discuss the value of USP and ChP public standards in helping assure the quality, safety and purported efficacy of the botanical dietary supplements, health foods and herbal medicines (DSHM) in the global supply chain through transparent science-based standards. Stakeholder input will be collected from trade associations, industry and academia to identify the needs and challenges related to current topics.


Contact:Chen Qitian,Liu Yan, Yu zhibin ,010-5803 6250/6251/6256、13651191920、

  • Session One: Keynote Presentations
  • 10:00-10:10 Opening Remark by ChP

    Dr. Wei Zhang,  Chinese Pharmacopoeia Commission  Secretary General

  • 10:10-10:20 Opening Remark by USP

    Dr. Gabriel Giancaspro  Science—Dietary Supplements & Herbal Medicines, USP  Vice President

  • 10:20-10:30 Opening Remark by US Consulate

    Sen Tan    U.S. Consulate General Shanghai

  • Session Two: DSHM Market Trends and Regulatory perspective in US and China
  • 10:30-10:50 ChP 2020 overview

    Dr. Wei Zhang,  Chinese Pharmacopoeia Commission  Secretary General

  • 10:50-11:20 Domestic and global trade of Chinese botanicals

    Ms.Meng Dongping    VicePresident, CCCMHPIE

  • 11:20-11:50 US Regulations for Botanical Dietary Supplements vs Botanical Drugs

    Latasha A. Robinson    US FDA China Office

  • 11:50-12:20 US-China botanical commerce – Opportunities and resources to address the challenges

    Aliza Totayo/Ming Yang  US Department of Commerce  

  • Session Three: DSHM Regulations and Quality Standards
  • 13:30-14:00 US Botanical Drug Guidance and Product Regulation

    Jing Li  US FDA Botanical Drug divisio  

  • 14:00-14:30 China TCM regulations and ChP TCM standards (ChP)


  • 14:30-15:00 USP Botanical standards – A Comprehensive Approach for Quality (USP)

    Dr.Gabriel Giancaspro  Science—Dietary Supplements & Herbal Medicines, USP  Vice President

  • 15:00-15:30 Risk assessment of heavy metal of Chinese medicinal herbs

    Zhang Lei    China National Center for Food Safety Risk Assessment (CFSA)

  • 15:30-16:00 Pesticide registration and administration in China and setting standards for pesticide residue limit in minor crops

    Zheng Zuntao    Pesticide Inspection Institute of the Ministry of Agriculture and Rural Areas

  • 16:00-16:20 Tea Break
  • Session Four: Industry Perspectives
  • 16:20-16:40 Topic TBD, China Nutrition and Health Food Association (CNHFA)
  • 16:40-17:00 TBD

    Qunyi Zheng  US Company perspective, Herbalife  Chairman

  • 17:00-17:20 Chinese Company Perspective, IVCN

    Liang Chang  IVCN  Chairman

  • 17:20-18:00 Panel Discussion
  • Panel Discussion